Stock APC.H ADVANCED PROTEOME THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advanced Proteome Therapeutics Corporation

Equities

APC.H

CA0076282098

Investment Holding Companies

Delayed Toronto S.E.
Other stock markets
 03:55:53 2023-12-04 pm EST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Advanced Proteome Therapeutics Corporation -.--% -.--%
2023 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
2023 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI

Valuation

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Capitalization 1 5.881 6.776 2.314 1.908 10.59 4.648
Enterprise Value (EV) 1 6.022 6.846 2.536 2.37 10.26 4.617
P/E ratio -7.55 x -8.5 x -6.94 x -3.48 x -4.85 x 6.03 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -5.87 x -6.55 x -2.85 x -4.33 x -15.8 x -4.93 x
EV / FCF -16.5 x -11.2 x -8.16 x -9.06 x -32.9 x -13.7 x
FCF Yield -6.05% -8.94% -12.2% -11% -3.04% -7.28%
Price to Book 8.12 x 12.2 x 3.47 x 6.62 x -35.1 x 4.35 x
Nbr of stocks (in thousands) 13,382 16,051 20,998 26,964 37,751 39,677
Reference price 2 0.4395 0.4221 0.1102 0.0708 0.2805 0.1172
Announcement Date 11/28/17 11/28/18 11/28/19 11/30/20 11/29/21 11/15/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -1.026 -1.045 -0.8903 -0.5476 -0.6482 -0.9366
EBIT 1 -1.035 -1.051 -0.8945 -0.5509 -0.6511 -0.9412
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.9018 -0.8929 -0.4614 -0.5415 -1.92 0.5975
Net income 1 -0.7217 -0.7448 -0.3335 -0.4506 -1.835 0.7596
Net margin - - - - - -
EPS 2 -0.0582 -0.0497 -0.0159 -0.0203 -0.0579 0.0194
Free Cash Flow 1 -0.3643 -0.6122 -0.3106 -0.2615 -0.312 -0.336
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/28/17 11/28/18 11/28/19 11/30/20 11/29/21 11/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Net Debt 1 0.14 0.07 0.22 0.46 - -
Net Cash position 1 - - - - 0.32 0.03
Leverage (Debt/EBITDA) -0.1373 x -0.0673 x -0.2489 x -0.8422 x - -
Free Cash Flow 1 -0.36 -0.61 -0.31 -0.26 -0.31 -0.34
ROE (net income / shareholders' equity) 141% 106% 51% 47.2% 112% -41.1%
ROA (Net income/ Total Assets) -428% -361% -319% -368% -88.7% -76.7%
Assets 1 0.1684 0.2061 0.1046 0.1224 2.069 -0.9905
Book Value Per Share 2 0.0500 0.0300 0.0300 0.0100 -0.0100 0.0300
Cash Flow per Share 2 0.0100 0.0100 0.0100 0 0.0200 0.0100
Capex - - 0 - 0 0.01
Capex / Sales - - - - - -
Announcement Date 11/28/17 11/28/18 11/28/19 11/30/20 11/29/21 11/15/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
ADVANCED PROTEOME THERAPEUTICS CORPORATION Stock Advanced Proteome Therapeutics Corporation
-.--% 150K
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+137.37% 5.68B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+1.89% 1.01B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.19% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+25.27% 819M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.68% 663M
E7 GROUP Stock E7 Group
+0.54% 610M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+21.31% 552M
Shell Companies
  1. Stock Market
  2. Equities
  3. APC.H Stock
  4. Financials Advanced Proteome Therapeutics Corporation